**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Chinese medical journal, 134(1), 4749.
No, Ivy Rx is not a compounding pharmacy
10.1056/NEJMOA1603827 29 MasiS.RizzoniD.TaddeiS.WidmerR
Lifestyle interventions including structured dietary programmes, increased physical activity, and behavioural support remain the cornerstone of sustainable weight management and should underpin any pharmacological approach
Countries backed by high healthcare expenditure, increasing awareness of obesity, and sustained efforts in clinical adoption of advanced therapies contribute to the expansion